Brown LM, Pottern LM, Silverman DT, et al.: Multiple myeloma among Blacks and Whites in the United States: role of cigarettes and alcoholic beverages. Cancer Causes Control 8:610-614, 1997. Brown LM, Gridley G, Pottern LM, et al.: Diet and nutrition as risk factors for multiple myeloma among blacks and whites in the US. Cancer Causes Control 12:117-125, 2001.

Pottern LM, Gart JJ, Nam JM, et al.: HLA and multiple myeloma among black and white men: evidence of a genetic association. Cancer Epidemiol Biomarkers Prev 1:177-182, 1992.

Garfinkel L: The epidemiology of cancer in black Americans. Stat Bull Metrop Insur Co 72:11-17, 1991. Modiano MR, Villar-Werstler P, Crowley J, Salmon SE: Evaluation of race as a prognostic factor in multiple myeloma. An ancillary of Southwest Oncology Group Study 8229. J Clin Oncol 14:974-977, 1996. Nossent JC, Winkel CN, van Leeuwen JC: Multiple myeloma in the Afro-Caribbean population of Curacao. Neth J Med 43:210-214, 1993. Kyle RA, Rajkumar SV: Monoclonal gammopathies of undetermined significance: a review. Immunol Rev 194:112-139, 2003.

Kyle RA, Therneau TM, Rajkumar SV, et al.: A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 346:564-569, 2002.

25. Singh J, Dudley AW Jr, Kulig KA: Increased incidence of monoclonal gammopathy of undetermined significance in blacks and its age-related differences with whites on the basis of a study of 397 men and one woman in a hospital setting. J Lab Clin Med 116:785-789, 1990.

26. Cohen HJ, Crawford J, Rao MK, Pieper CF, Currie MS: Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly. Am J Med 104:439-444, 1998.

27. Giraldo P, Rubio-Felix D, Cortes T, et al.: [Incidence, clinico-biological characteristics, and clinical course of 1,203 monoclonal gammopathies (1971-1992)]. Sangre (Barc) 39:343-350, 1994.

28. Ogmundsdottir HM, Haraldsdottir V, Johammesson G, et al.: Monoclonal gammopathy in Iceland: a population-based registry and follow-up. Br J Haematol 118: 166-173, 2002.

29. Pasqualetti P, Collacciani A, Casale R: Risk of monoclonal gammopathy of undetermined significance: a case-referent study. Am J Hematol 52:217-220, 1996.

30. Karlson EW, Tanasijevic M, Hankinson SE, et al.: Monoclonal gammopathy of undetermined significance exposure to breast implants. Arch Intern Med 161:864-867, 2001.

31. Neriishi K, Nakashima E, Suzuki G: Monoclonal gam-mopathy of undetermined significance in atomic bomb survivors: incidence and transformation to multiple myeloma. Br J Haematol 121:405-410, 2003.

32. Doody MM, Linet MS, Glass AG, et al.: Leukemia, lymphoma, and multiple myeloma following selected medical conditions. Cancer Causes Control 3:449-456, 1992.

33. Linet MS, Harlow SD, McLaughlin JK: A case-control study of multiple myeloma in whites: chronic anti-genic stimulation, occupation, and drug use. Cancer Res 47:2978-2981, 1987.

34. Pinkhas J, Djaldetti M, Yaron M: Coincidence of multiple myeloma with Gaucher's disease. Isr J Med Sci 1:537-540, 1965.

35. Moneret-Vautrin DA, Grilliat JP, Gaucher P, et al.: [Gastric plasmacytosarcoma with IgA dysglobuline-mia]. NouvPresse Med 4:2799-2803, 1975.

36. Benjamin D, Joshua H, Djaldetti M, Hazaz B, Pinkhas J: Nonsecretory IgD-kappa multiple myeloma in a patient with Gaucher's disease. Scand J Haematol 22:179-184,

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment